| Date Filed | Type | Description |
| 04/04/2023 |
4
| Templeman Thomas (Chief Technology Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 4,103 shares
@ $3.9, valued at
$16k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2023 |
4
| Templeman Thomas (Chief Technology Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 5,382 shares
@ $4.25, valued at
$22.9k
|
|
| 01/04/2023 |
4
| Templeman Thomas (Chief Technology Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 2,921 shares
@ $3.1, valued at
$9.1k
|
|
| 11/23/2022 |
4/A
| Templeman Thomas (Chief Technology Officer) has filed a Form 4 on Centessa Pharmaceuticals plc |
| 10/04/2022 |
4
| Templeman Thomas (Chief Technology Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Sold 2,003 shares
@ $4.0674, valued at
$8.1k
Sold 2,455 shares
@ $3.9501, valued at
$9.7k
|
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Templeman Thomas (Chief Technology Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Bought 250 shares
@ $20, valued at
$5k
Granted 500,338 options to buy
@ $0 |
|
| 05/27/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
3
| Templeman Thomas (SVP, Pharmaceutical Ops) has filed a Form 3 on Nuvation Bio Inc. |